CHA Biotech Co. Ltd (085660) - Total Liabilities

Latest as of March 2026: ₩1.77 Trillion KRW ≈ $1.20 Billion USD

Based on the latest financial reports, CHA Biotech Co. Ltd (085660) has total liabilities worth ₩1.77 Trillion KRW (≈ $1.20 Billion USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore 085660 net asset momentum to track the company's year-over-year net asset growth rate.

CHA Biotech Co. Ltd - Total Liabilities Trend (2008–2025)

This chart illustrates how CHA Biotech Co. Ltd's total liabilities have evolved over time, based on quarterly financial data. See CHA Biotech Co. Ltd free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.

CHA Biotech Co. Ltd Competitors by Total Liabilities

The table below lists competitors of CHA Biotech Co. Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
Societe de la Tour Eiffel SA PA:EIFF	France	€541.80 Million
Amos Luzon Development and Energy Group Ltd TA:LUZN	Israel	ILA2.70 Billion
Gresgying Digital Energy Technology Co Ltd SHG:600212	China	CN¥1.28 Billion
Bansal Wire Industries Ltd NSE:BANSALWIRE	India	Rs10.86 Billion
Nanjing Develop Advanced Manufacturing Co Ltd SHG:688377	China	CN¥897.59 Million
Sarkuysan Elektrolitik Bakir Sanayi ve Ticaret AS IS:SARKY	Turkey	TL13.79 Billion
Invesco Mortgage Capital Inc NYSE:IVR	USA	$5.68 Billion
Datamatics Global Services Limited NSE:DATAMATICS	India	Rs7.08 Billion

Liability Composition Analysis (2008–2025)

This chart breaks down CHA Biotech Co. Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see CHA Biotech Co. Ltd market capitalisation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	0.88	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	3.43	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.63	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how CHA Biotech Co. Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for CHA Biotech Co. Ltd (2008–2025)

The table below shows the annual total liabilities of CHA Biotech Co. Ltd from 2008 to 2025.

Year	Total Liabilities	Change
2025-12-31	₩1.74 Trillion ≈ $1.18 Billion	-8.97%
2024-12-31	₩1.91 Trillion ≈ $1.29 Billion	+78.60%
2023-12-31	₩1.07 Trillion ≈ $724.61 Million	-18.71%
2022-12-31	₩1.32 Trillion ≈ $891.34 Million	+21.89%
2021-12-31	₩1.08 Trillion ≈ $731.27 Million	+12.57%
2020-12-31	₩958.62 Billion ≈ $649.64 Million	+22.00%
2019-12-31	₩785.74 Billion ≈ $532.48 Million	+26.62%
2018-12-31	₩620.54 Billion ≈ $420.53 Million	+10.25%
2017-12-31	₩562.87 Billion ≈ $381.45 Million	+16.63%
2016-12-31	₩482.61 Billion ≈ $327.06 Million	+36.05%
2015-12-31	₩354.73 Billion ≈ $240.39 Million	+93.39%
2014-12-31	₩183.43 Billion ≈ $124.31 Million	+5.96%
2013-12-31	₩173.12 Billion ≈ $117.32 Million	-7.45%
2012-12-31	₩187.06 Billion ≈ $126.76 Million	-1.32%
2011-12-31	₩189.56 Billion ≈ $128.46 Million	+7.67%
2010-12-31	₩176.06 Billion ≈ $119.32 Million	+71.36%
2009-12-31	₩102.75 Billion ≈ $69.63 Million	+402.00%
2008-12-31	₩20.47 Billion ≈ $13.87 Million	--

About CHA Biotech Co. Ltd

KQ:085660 Korea Biotechnology

Market Cap

$532.39 Million

₩785.59 Billion KRW

Market Cap Rank

#11707 Global

#301 in Korea

Share Price

₩8450.00

Change (1 day)

+5.23%

52-Week Range

₩8030.00 - ₩23850.00

All Time High

₩40950.00